NCCN Asian Consensus Statement - Can Asian patients with cancer accept treatment modalities from NCCN guidelines?

Seiichiro Ozono, Shiro Hinotsu, Mikio Namiki, Hideyuki Akaza

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Fingerprint

Dive into the research topics of 'NCCN Asian Consensus Statement - Can Asian patients with cancer accept treatment modalities from NCCN guidelines?'. Together they form a unique fingerprint.

Medicine & Life Sciences